Investigating the effect of probiotic on the treatment of Helicobacter pylori infection in patients referred

Investigating the effect of probiotic on the treatment of Helicobacter pylori infection in patients referred to Imam Reza Hospital in 1403

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20250915067259N1

Enrollment

180

Registered

2025-10-27

Start date

2025-09-29

Completion date

Unknown

Last updated

2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Helicobacter pylori infection. Helicobacter pylori [H. pylori] as the cause of diseases classified elsewhere

Interventions

Intervention 1: Intervention group: Probiotic along with a regimen of clarithromycin 500 mg twice daily + amoxicillin 1 g twice daily + omeprazole 20 mg twice daily for two weeks. Intervention 2: Inte

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: All patients referred to the Gastroenterology and Infectious Diseases Clinic of Imam Reza Hospital whose Helicobacter pylori infection has been confirmed through fecal antigen testing, respiratory urease, or endoscopic biopsy.

Exclusion criteria

Exclusion criteria: Patients referred to the Gastroenterology and Infectious Diseases Clinic of Imam Reza Hospital whose Helicobacter pylori infection has not been confirmed by fecal antigen test, respiratory urease, or endoscopic biopsy.

Design outcomes

Primary

Measure	Time frame
Helycobacter pylori infection. Timepoint: At the begining of the study and 4 to 6 weeks later. Method of measurement: Stool antigen test.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammad Pasdar

Artesh University of Medical Sciences

mhmdpsdr@gmail.com009886705503

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026